1. Home
  2. DNLI vs BANC Comparison

DNLI vs BANC Comparison

Compare DNLI & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • BANC
  • Stock Information
  • Founded
  • DNLI 2013
  • BANC 1941
  • Country
  • DNLI United States
  • BANC United States
  • Employees
  • DNLI N/A
  • BANC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BANC Major Banks
  • Sector
  • DNLI Health Care
  • BANC Finance
  • Exchange
  • DNLI Nasdaq
  • BANC Nasdaq
  • Market Cap
  • DNLI 2.1B
  • BANC 2.4B
  • IPO Year
  • DNLI 2017
  • BANC N/A
  • Fundamental
  • Price
  • DNLI $13.60
  • BANC $14.20
  • Analyst Decision
  • DNLI Strong Buy
  • BANC Buy
  • Analyst Count
  • DNLI 16
  • BANC 13
  • Target Price
  • DNLI $37.57
  • BANC $18.08
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • BANC 2.8M
  • Earning Date
  • DNLI 05-06-2025
  • BANC 04-22-2025
  • Dividend Yield
  • DNLI N/A
  • BANC 2.83%
  • EPS Growth
  • DNLI N/A
  • BANC N/A
  • EPS
  • DNLI N/A
  • BANC 0.52
  • Revenue
  • DNLI N/A
  • BANC $960,394,000.00
  • Revenue This Year
  • DNLI N/A
  • BANC $12.66
  • Revenue Next Year
  • DNLI $497.02
  • BANC $10.63
  • P/E Ratio
  • DNLI N/A
  • BANC $27.36
  • Revenue Growth
  • DNLI N/A
  • BANC 289.07
  • 52 Week Low
  • DNLI $13.30
  • BANC $11.88
  • 52 Week High
  • DNLI $33.33
  • BANC $18.08
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 34.19
  • BANC 46.14
  • Support Level
  • DNLI $13.67
  • BANC $13.85
  • Resistance Level
  • DNLI $14.84
  • BANC $14.97
  • Average True Range (ATR)
  • DNLI 0.77
  • BANC 0.43
  • MACD
  • DNLI 0.12
  • BANC 0.10
  • Stochastic Oscillator
  • DNLI 9.90
  • BANC 50.64

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: